Skip to main navigation Skip to search Skip to main content

Active surveillance of candidemia in children from latin america: A key requirement for improving disease outcome

  • Maria E. Santolaya
  • , Tito Alvarado
  • , Flavio Queiroz-Telles
  • , Arnaldo L. Colombo
  • , Jeanette Zurita
  • , Iris N. Tiraboschi
  • , Jorge Alberto Cortes
  • , Luis Thompson
  • , Manuel Guzman
  • , Jose Sifuentes
  • , Juan I. Echevarría
  • , Marcio Nucci
  • Fundación Arriaran–Facultad de Medicina Universidad de Chile
  • Hospital Escuela
  • Universidade Federal do Paraná
  • Federal University of São Paulo
  • Pontificia Universidad Católica del Ecuador
  • Universidad de Buenos Aires
  • National University of Colombia
  • Universidad Del Desarrollo
  • Hospital Vargas de Caracas
  • Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”
  • Universidade Federal do Rio de Janeiro

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Abstract

BACKGROUND:: Active surveillance is necessary for improving the management and outcomes of patients with candidemia. The aim of this study was to describe the epidemiologic and clinical features of candidemia in pediatric patients in Latin America. METHOD:: Prospective, multicenter, surveillance study of candidemia in a pediatric population from 23 hospitals in 8 Latin America countries between November 2008 and October 2010. RESULTS:: Three hundred and two cases of candidemia were reported with a median incidence of 0.81/1000 admissions. Eighty nine (29%) were neonates. The main risk factors were prematurity, intensive care unit (ICU) admission, parenteral nutrition, respiratory disease and mechanical ventilation in neonates and malignancy, neutropenia, neurological disease and previous use of corticosteroids in children. The main species isolated in neonates and children were Candida albicans (43.8% and 35.7%), Candida parapsilosis (27.0% and 26.3%) and Candida tropicalis (14.6% and 14.6%), respectively. The most frequent antifungal therapy used in neonates and children was deoxycholate-amphotericin-B (43.8% and 29.1%) and fluconazole (28.1% and 53.1%). Seventeen neonates (19.1%) and 20 children (9.4%) did not receive antifungal therapy. The 30-day survival rate was 60% in neonates and 72% in children (P = 0.02). Survival was significantly higher in treated than in nontreated neonates (72% vs. 24%; P < 0.001). A multivariate analysis showed that independent predictors for 30-day mortality in children were renal disease (odds ratio: 4.38, 95% confidence interval: 1.92-10.1, P < 0.001) and receipt of corticosteroids (odds ratio: 2.08, 95% confidence interval: 1.04-4.17, P = 0.04). CONCLUSIONS:: To our knowledge, this is the first prospective, multicenter surveillance study of candidemia in children in Latin America. This epidemiologic information may provide us with methods to improve preventive, diagnostic and therapeutic strategies in our continent.

Original languageEnglish
Pages (from-to)e40-e44
JournalPediatric Infectious Disease Journal
Volume33
Issue number2
DOIs
StatePublished - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Candidemia
  • Latin America
  • children
  • epidemiology

Fingerprint

Dive into the research topics of 'Active surveillance of candidemia in children from latin america: A key requirement for improving disease outcome'. Together they form a unique fingerprint.

Cite this